ChemMedChem · 2015 · 204 citations · 32 references
PharmacyMedicinal ChemistryPharmacokineticsDrug DiscoveryOrganic ChemistryStructure-activity RelationshipsDrug DispositionLipophilicity ModulationQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisStructure-metabolism RelationshipsChemical SubstituentsMedicinal Chemistry ApplicationsMetabolic Stability ModulationMolecular LipophilicityPhysicochemical DescriptorsPhysicochemical PropertiesStructure - Pharmacokinetic Relationship AnalysisSynthetic Analogues
The tert-butyl group is a common motif in medicinal chemistry. Its incorporation into bioactive compounds is often accompanied by unwanted property modulation, such as increased lipophilicity and decreased metabolic stability. Several alternative substituents are available for the drug discovery process. Herein, physicochemical data of two series of drug analogues of bosentan and vercirnon are documented as part of a comparative study of tert-butyl, pentafluorosulfanyl, trifluoromethyl, bicyclo[1.1.1]pentanyl, and cyclopropyl-trifluoromethyl substituents.
32
Bosentan Therapy for Pulmonary Arterial Hypertension
Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text
Antonia F. Stepan, Chakrapani Subramanyam, Ivan Efremov et al. · Journal of Medicinal Chemistry · 2012 · 446 citations · Full text
Salbutamol: a new, selective β‐adrenoceptive receptor stimulant
VALERIE A. CULLUM, J B Farmer, David Jack et al. · British Journal of Pharmacology · 1969 · 297 citations · Full text
José M. Coterón, María Marco, Jorge Esquivias et al. · Journal of Medicinal Chemistry · 2011 · 284 citations · Full text
Oxetanes as Promising Modules in Drug Discovery
Georg Wuitschik, Mark Rogers‐Evans, Klaus Müller et al. · Angewandte Chemie International Edition · 2006 · 257 citations